Ewing's sarcoma family tumors of the humerus: Outcome of patients treated with radiotherapy, surgery or surgery and adjuvant radiotherapy

Radiotherapy and Oncology

Volumn 93, Issue 2, 2009, Pages 383-387

  Bacci, Gaetano ^a   Palmerini, Emanuela ^a   Staals, Eric L ^a   Longhi, Alessandra ^a   Barbieri, Enza ^a   Alberghini, Marco ^a   Ferrari, Stefano ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Ewing's sarcoma; Humerus; Radiotherapy; Surgery

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BONE TUMOR; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CONTROL GROUP; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; EWING SARCOMA; FEMALE; FOLLOW UP; HUMAN; HUMERUS; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; OUTCOME ASSESSMENT; PATHOLOGIC FRACTURE; PATIENT ASSESSMENT; POSTOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS FAILURE; QUALITY OF LIFE; RADIATION DOSE; RECURRENCE RISK; SCHOOL CHILD; TUMOR VOLUME;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HUMERUS; MALE; RADIOTHERAPY, ADJUVANT; SARCOMA, EWING'S; TREATMENT OUTCOME;

EID: 70350512355     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.06.009     Document Type: Article

References (28)

1. Boyer C.W., Brickner T.J., and Perry R.H. Ewing's sarcoma: case against surgery. Cancer 20 (1967) 1602-1606
2. Falk S., and Alpert M. Five-year survival of patients with Ewing's sarcoma. Surg Gynecol Obstet 124 (1967) 319-324
3. Jurgens H., Exner U., Gadner H., et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European cooperative trial. Cancer 61 (1988) 23-32
4. Burgert Jr. E.O., Nesbit M.E., and Garnsey L.A. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone. Intergroup study IESS-II. J Clin Oncol 8 (1990) 1514-1824
5. Nesbit Jr. M.E., Gehan E.A., Burgert Jr. E.O., et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the first intergroup study. J Clin Oncol 8 (1990) 1664-1674
6. Craft A.W., Cotterill S.J., Bullimore J.A., and Pearson D. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 33 (1997) 1061-1069
7. Nilbert M., Saeter G., Elomaa I., Monge O.R., Wiebe T., and Alvegård T.A. Ewing's sarcoma treatment in Scandinavia 1984-1990: ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV. Acta Oncol 37 (1998) 375-378
8. Terek R.M., Brien E.W., Marcove R.C., Meyers P.A., Lane J.M., and Healey J.H. Treatment of femoral Ewing's sarcoma. Cancer 78 (1996) 70-78
9. Damron T.A., Sim F.H., O'Connor M.I., Pritchard D.J., and Smithson W.A. Ewing's sarcoma of the proximal femur. Clin Orthop Relat Res 322 (1996) 232-244
10. Ozaki T., Hillmann A., Hoffmann C., et al. Ewing's sarcoma of the femur. Prognosis in 69 patients treated by the CESS group. Acta Orthop Scand 68 (1997) 20-24
11. Bacci G., Ferrari S., Longhi A., et al. Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery. J Bone Joint Surg Br 85 (2003) 107-114
12. Göbel V., Jürgens H., Etspüler G., et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescent. J Cancer Res Clin Oncol 113 (1987) 187-191
13. Enneking W., Dunham W., Gebhardt M., Malawar M., and Pritchard D. A system for the classification of skeletal resections. Chir Organi Mov 75 (1990) 217-240
14. Picci P., Rougraff B.T., Bacci G., et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol 11 (1993) 1763-1769
15. Barbieri E., Frezza G., Martelli O., et al. Non conventional fractionation in radiotherapy of the musculo-skeletal sarcomas. Tumori 84 (1998) 167-170
16. Bacci G., Ferrari S., Longhi A., et al. Role of surgery in local treatment of Ewing's sarcoma of the extremities in patients undergoing adjuvant and neoadjuvant chemotherapy. Oncol Rep 11 (2004) 111-120
17. Enneking W.F. Modification of the system for functional evaluation in the surgical management of musculoskeletal tumors. In: Enneking W.F. (Ed). Limb salvage in musculoskeletal oncology (1987), Churchill Livingstone, New York 626-639
18. Bacci G., Campanacci M., and Pagani P.A. Adjuvant chemotherapy in the treatment of clinically localised Ewing's sarcoma. J Bone Joint Surg Br 60-B (1978) 567-574
19. Bacci G., Ferrari S., Bertoni F., et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 18 (2000) 4-11
20. Evans R., Nesbit M., Askin F., et al. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones. Int J Radiat Oncol Biol Phys 11 (1985) 129-136
21. Jentzsch K., Binder H., Cramer H., et al. Leg function after radiotherapy for Ewing's sarcoma. Cancer 47 (1981) 1267-1278
22. Lewis R.J., Marcove R.C., and Rosen G. Ewing's sarcoma: functional effects of radiation therapy. J Bone Joint Surg Am 59 (1977) 325-331
23. Greene M.H., Glaubiger D.L., Mead G.D., and Fraumeni Jr. J.F. Subsequent cancer in patients with Ewing's sarcoma. Cancer Treat Rep 63 (1979) 2043-2046
24. Kuttesch Jr. J.F., Wexler L.H., Marcus R.B., et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 14 (1996) 2818-2825
25. Bacci G., Picci P., Ferrari S., et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase. Results of two sequential studies. Cancer 82 (1998) 1174-1183
26. Tefft M., Razek A., Perez C., et al. Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing's sarcoma of pelvic bones. Int J Radiat Oncol Biol Phys 4 (1978) 367-372
27. Glaubiger D.L., Makuch R.W., and Schwarz J. Influence of prognostic factors on survival in Ewing's sarcoma. Natl Cancer Inst Monogr 56 (1981) 285-288
28. Cotteril S.J., Arhens S., and Paulussen M. Prognostic factors in Ewing's tumor of bone. Analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18 (2000) 3108-3114